Gardiner E E, Karunakaran D, Shen Y, Arthur J F, Andrews R K, Berndt M C
Department of Immunology, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Vic. Australia.
J Thromb Haemost. 2007 Jul;5(7):1530-7. doi: 10.1111/j.1538-7836.2007.02590.x. Epub 2007 Apr 18.
Platelet glycoprotein (GP)VI that binds collagen, and GPIb-IX-V that binds von Willebrand factor, initiate thrombus formation.
In this study, we investigated the mechanisms of metalloproteinase-mediated ectodomain shedding that regulate the surface expression of GPVI, GPIbalpha (the major ligand-binding subunit) and GPV (that regulates thrombin-dependent activation via GPIbalpha).
Immunoblotting human platelet lysates using affinity-purified antibodies against cytoplasmic domains of GPVI, GPIbalpha or GPV allowed simultaneous analysis of intact and cleaved receptor, and revealed (i) that a significant fraction of GPIbalpha, but not GPVI, exists in a cleaved state on platelets, even when isolated in the presence of metalloproteinase inhibitor (GM6001) or EDTA; (ii) the same-sized membrane-associated fragments of GPVI or GPIbalpha are generated by phorbol-ester (PMA), the mitochondrial-targeting reagent CCCP, the calmodulin inhibitor W7, or the thiol-modifying reagent, N-ethylmaleimide, that directly activates ADAM10/ADAM17; and (iii) GPV is shed by both metalloproteinase- and thrombin-dependent mechanisms, depending on the concentration of thrombin. Based on the predicted cleavage area defined by these studies, ADAM10, but not ADAM17, cleaved a GPVI-based synthetic peptide within the extracellular membrane-proximal sequence (PAR;Q(243)YY) as analyzed by MALDI-TOF-MS. In contrast, ADAM17, but not ADAM10, cleaved within the GPIbalpha-based peptide (LRG;V(465)LQ). Both ADAM10 and ADAM17 cleaved within a GPV-based peptide (AQP;V(494)TT). Metalloproteinase-mediated shedding of GPIbalpha from GPIb-IX-transfected or GPVI-transfected cells induced by W7 or N-ethylmaleimide was inhibited by mutagenesis of sequences identified from peptide analysis.
These findings suggest surface levels of GPVI, GPIbalpha and GPV may be controlled by distinct mechanisms involving ADAM10 and/or ADAM17.
与胶原蛋白结合的血小板糖蛋白(GP)VI以及与血管性血友病因子结合的GPIb-IX-V启动血栓形成。
在本研究中,我们调查了金属蛋白酶介导的胞外域脱落调节GPVI、GPIbalpha(主要配体结合亚基)和GPV(通过GPIbalpha调节凝血酶依赖性激活)表面表达的机制。
使用针对GPVI、GPIbalpha或GPV胞质域的亲和纯化抗体对人血小板裂解物进行免疫印迹,可同时分析完整和裂解的受体,并揭示:(i)即使在金属蛋白酶抑制剂(GM6001)或乙二胺四乙酸(EDTA)存在下分离,相当一部分GPIbalpha而非GPVI以裂解状态存在于血小板上;(ii)佛波酯(PMA)、线粒体靶向试剂羰基氰化物间氯苯腙(CCCP)、钙调蛋白抑制剂W7或直接激活ADAM10/ADAM17的硫醇修饰试剂N-乙基马来酰亚胺可产生相同大小的GPVI或GPIbalpha膜相关片段;(iii)GPV通过金属蛋白酶依赖性和凝血酶依赖性机制脱落,这取决于凝血酶的浓度。基于这些研究确定的预测裂解区域,基质金属蛋白酶10(ADAM10)而非基质金属蛋白酶17(ADAM17)可裂解细胞外膜近端序列(PAR;Q(243)YY)内基于GPVI的合成肽,这通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)分析得出。相反,ADAM17而非ADAM10可在基于GPIbalpha的肽(LRG;V(465)LQ)内裂解。ADAM10和ADAM17均可在基于GPV的肽(AQP;V(494)TT)内裂解。W7或N-乙基马来酰亚胺诱导的从转染GPIb-IX或转染GPVI的细胞中金属蛋白酶介导的GPIbalpha脱落可通过肽分析鉴定的序列诱变来抑制。
这些发现表明,GPVI、GPIbalpha和GPV的表面水平可能受涉及ADAM10和/或ADAM17的不同机制控制。